Evaluation of Hypertension in Pediatric Hemolytic Uremic Syndrome (A Cross-Sectional Study)

Mahdi Banaei Nourmohammadi1, Fahimeh Askarian2, Arash Abbasi2

  • 1Tehran University of Medical Sciences Tehran Iran.

Health Science Reports
|November 24, 2025
PubMed

Insights

Hypertension (HTN) affects nearly half of children with hemolytic uremic syndrome (HUS), a kidney condition. This HTN is linked to heart issues and low potassium, highlighting the need for close monitoring in pediatric HUS patients.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Health in Children
  • Critical Care Medicine

Background:

  • Hemolytic uremic syndrome (HUS), especially Shiga toxin-producing *Escherichia coli* (STEC)-associated HUS, is a leading cause of acute kidney injury (AKI) in children.
  • Hypertension (HTN) is a known complication of HUS, but its prevalence and risk factors in pediatric populations are understudied.

Purpose of the Study:

  • To determine the prevalence of HTN in children diagnosed with HUS.
  • To identify clinical correlates and potential risk factors associated with HTN in these patients, including laboratory findings and cardiac involvement.

Main Methods:

  • A descriptive cross-sectional study involving 50 pediatric HUS patients hospitalized between 2021 and 2024.
  • Data collection included blood pressure, BMI, renal function markers, and echocardiographic findings.
  • Statistical analysis utilized SPSS v26, employing t-tests, chi-square, and Fisher's exact tests to analyze associations.

Main Results:

  • Hypertension (HTN) was present in 48% of the pediatric HUS patients.
  • HTN showed significant associations with hypokalemia (p=0.011) and cardiac involvement (p=0.045).
  • No significant associations were found between HTN and age, sex, BMI, HUS type, urea, creatinine, or hemoglobin levels.

Conclusions:

  • This study underscores the significant prevalence of HTN in pediatric HUS patients.
  • HTN in HUS is associated with cardiac complications and electrolyte imbalances, particularly hypokalemia.
  • Routine blood pressure monitoring and cardiovascular assessments are crucial for managing pediatric HUS, with recommendations for lifelong follow-up.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
451
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
196
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
247
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
249